Page 2 - Eric Soyer News Today

PHAXIAM Therapeutics extends its phage portfolio to Klebsiella pneumoniae, a new resistant and aggressive bacterial target Klebsiella pneumoniae is responsible for severe infections and stands out...

18.09.2023 - PRESS RELEASE PHAXIAM Therapeutics announces the completion of its reverse share split Lyon (France) and Cambridge (MA, US), September 18th, 2023 - PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM) (the Company), announces the completion today of ...

ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics Merger approved with large majority by the shareholders of both companiesNew governance structure implementedAmbition to create a global leader in extended phage therapies to ...

         ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023 All resolutions voted with a large majority ac...

ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit Cambridge, MA and Lyon , June 20, 2023 – ERYTECH Pharma announces the filing of... | June 20, 2023

ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma Cambridge, MA (U.S.) and Lyon (France), June 14

ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma Cambridge, MA...

ERYTECH announces that the Commercial Court has rejected Akkadians request to postpone the vote on the merger with Pherecydes Pharma Cambridge, MA and Lyon , June 14, 2023, 8:00 pm CEST –... | June 16, 2023

ERYTECH Responds to Akkadian’s Disinformation          Akkadian’s challenge of the merger is based on incomplete information and misleading... | June 12, 2023

... | June 12, 2023